Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization

Ítems similars

• Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization
  per: Triana Amen, et al.
  Publicat: (2016-03-01)
• Inhibition of Aβ(42) oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
  per: Park, Sei-Kyoung, et al.
  Publicat: (2016)
• Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
  per: Sei-Kyoung Park, et al.
  Publicat: (2016-01-01)
• FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal
  per: Mei, Yikun, et al.
  Publicat: (2020)
• Integrative modules for efficient genome engineering in yeast
  per: Amen, Triana, et al.
  Publicat: (2017)